Chicago Tribune

Mammography screening for breast cancer saves lives. But another test may be better for women with dense breasts. Dr. Deborah Rhodes, an internal medicine specialist from the Breast Diagnostic Clinic at Mayo Clinic, says that data from a study being done at Mayo Clinic and other centers across the country suggest that molecular breast imaging may also be better than 3D mammography. “MBI is a relatively new tool for imaging the breast that was designed to overcome the limitations of mammography for imaging the dense breast,” says Rhodes.

Reach:  The Tribune’s average weekday circulation is more about 238,000. Average Sunday circulation is more than 519,600. The Chicago Tribune’s website receives more than 23.9 million unique visitors each month.

Additional coverage:
South Florida Reporter, What Is Molecular Breast Imaging And Who Needs It? (Video)

Context: October is National Breast Cancer Awareness Month, a great time to spread the word about the importance breast cancer screening and being alert to breast changes. After skin cancer, breast cancer is the most common type of cancer diagnosed in women in the U.S. Deborah Rhodes, M.D., an internal medicine physician in the Breast Diagnostic Clinic at Mayo Clinic , says that women of all ages should be aware of changes in their breasts and seek medical advice if they notice anything unusual. You can read and view more here.

Tags: Breast Cancer, Chicago Tribune, Dr. Deborah Rhodes, molecular breast imaging, Uncategorized